CP and inflammatory bowel disease: The wider detection range offered by our CRISPR sensor is sufficient to cover most biological concentrations typically found in clinical serum samples from healthy (~200–4000 ng/ml) and IBD (~410–125,000 ng/ml) patients,9, 10 although mucosal CP levels have never been measured in humans previously.